Effects of chronic disease self-management programs for participants with higher depression scores: secondary analyses of an on-line and a small-group program

Abstract

Depression often accompanies chronic illness. Study aims included determining (1) the level of current depression (Patient Health Questionnaire (PHQ)-8≥10) for two sets of Chronic Disease Self-Management Programs (CDSMP) participants; (2) if depression or other outcomes improved for those with PHQ-8≥10; and (3) if outcomes differed for participants with or without depression. This study utilized longitudinal secondary data analysis of depression cohorts (PHQ-8≥10) from two independent translational implementations of the CDSMP, small-group (N=175) and Internet-based (N= 110). At baseline, 27 and 55 % of the two samples had PHQ-8 10 or greater. This decreased to 16 and 37 % by 12 months (p<0.001). Both depressed and nondepressed cohorts demonstrated improvements in most 12-month outcomes (pain, fatigue, activity limitations, and medication adherence). The CDSMP was associated with long-term improvements in depression regardless of delivery mode or location, and the programs appeared beneficial for participants with and without depression.

Effectiveness of a chronic disease self-management program in Mexico: A randomized controlled study

“…Previous studies examining the effectiveness of the CDSPM English-version and Tomando Control de su Salud targeting Spanish-speaking Hispanics in the United States found similar results. [5,[25][26][27][28][29][30] The ability to communicate with physicians is a significant self-management behavior for persons with chronic illnesses. Chronic disease self-management programs educate patients play a central role in making decisions and being responsible for managing their disease.…”

Determining the efficacy of the chronic disease self‐management programme and readability of ‘living a healthy life with chronic conditions’ in a New Zealand setting

“…The ES was calculated to support the interpretation of the magnitude of the outcomes beyond significance or otherwise. Using Cohen's ES interpretation, an ES of <0.2 is small; an ES of 0.2–0.8 is moderate; and an ES of >0.8 is large …”

Challenges in the clinical implementation of a biopsychosocial model for assessment and management of orofacial pain

“…In addition, individuals in the lower socioeconomic strata are seldom able to access the sophisticated treatments commonly recommended for persistent pain, such as cognitive‐behavioural therapies (CBT) which were developed in university clinics. Simplification of such therapies, including recognising the value of comprehensive self‐care methods within group sessions and telehealth contexts, could improve access as well as efficiency.…”